Literature DB >> 36191221

Early death in a mouse model of Alzheimer's disease exacerbated by microglial loss of TAM receptor signaling.

Youtong Huang1, Greg Lemke1.   

Abstract

Recurrent seizure is a common comorbidity in early-stage Alzheimer's disease (AD) and may contribute to AD pathogenesis and cognitive decline. Similarly, many mouse models of Alzheimer's disease that overproduce amyloid beta are prone to epileptiform seizures that may result in early sudden death. We studied one such model, designated APP/PS1, and found that mutation of the TAM receptor tyrosine kinase (RTK) Mer or its ligand Gas6 greatly exacerbated early death. Lethality was tied to violent seizures that appeared to initiate in the dentate gyrus (DG) of the hippocampus, where Mer plays an essential role in the microglial phagocytosis of both apoptotic and newborn cells normally generated during adult neurogenesis. We found that newborn DG neurons and excitatory synapses between the DG and the cornu ammonis field 3 (CA3) field of the hippocampus were increased in TAM-deficient mice, and that premature death and adult neurogenesis in these mice were coincident. In contrast, the incidence of lethal seizures and the deposition of dense-core amyloid plaques were strongly anticorrelated. Together, these results argue that TAM-mediated phagocytosis sculpts synaptic connectivity in the hippocampus, and that seizure-inducing amyloid beta polymers are present prior to the formation of dense-core plaques.

Entities:  

Keywords:  Mertk; adult neurogenesis; hippocampus; microglia; seizures

Mesh:

Substances:

Year:  2022        PMID: 36191221      PMCID: PMC9564325          DOI: 10.1073/pnas.2204306119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  87 in total

1.  Sparse, environmentally selective expression of Arc RNA in the upper blade of the rodent fascia dentata by brief spatial experience.

Authors:  M K Chawla; J F Guzowski; V Ramirez-Amaya; P Lipa; K L Hoffman; L K Marriott; P F Worley; B L McNaughton; C A Barnes
Journal:  Hippocampus       Date:  2005       Impact factor: 3.899

2.  Antiepileptics topiramate and levetiracetam alleviate behavioral deficits and reduce neuropathology in APPswe/PS1dE9 transgenic mice.

Authors:  Jian-Quan Shi; Bian-Rong Wang; You-Yong Tian; Jun Xu; Li Gao; Shu-Li Zhao; Teng Jiang; Hong-Guang Xie; Ying-Dong Zhang
Journal:  CNS Neurosci Ther       Date:  2013-07-27       Impact factor: 5.243

Review 3.  Neural stem cells: origin, heterogeneity and regulation in the adult mammalian brain.

Authors:  Kirsten Obernier; Arturo Alvarez-Buylla
Journal:  Development       Date:  2019-02-18       Impact factor: 6.868

Review 4.  TAM Receptor Tyrosine Kinases in Cancer Drug Resistance.

Authors:  Mikaella Vouri; Sassan Hafizi
Journal:  Cancer Res       Date:  2017-05-19       Impact factor: 12.701

5.  SIRT3 Haploinsufficiency Aggravates Loss of GABAergic Interneurons and Neuronal Network Hyperexcitability in an Alzheimer's Disease Model.

Authors:  Aiwu Cheng; Jing Wang; Nathaniel Ghena; Qijin Zhao; Isabella Perone; Todd M King; Richard L Veech; Myriam Gorospe; Ruiqian Wan; Mark P Mattson
Journal:  J Neurosci       Date:  2019-12-09       Impact factor: 6.167

6.  Altered patterning of dentate granule cell mossy fiber inputs onto CA3 pyramidal cells in limbic epilepsy.

Authors:  John J McAuliffe; Stefanie L Bronson; Michael S Hester; Brian L Murphy; Renée Dahlquist-Topalá; David A Richards; Steve C Danzer
Journal:  Hippocampus       Date:  2011-01       Impact factor: 3.899

Review 7.  Interleukin 18 in the CNS.

Authors:  Silvia Alboni; Davide Cervia; Shuei Sugama; Bruno Conti
Journal:  J Neuroinflammation       Date:  2010-01-29       Impact factor: 8.322

8.  Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model.

Authors:  Pascal E Sanchez; Lei Zhu; Laure Verret; Keith A Vossel; Anna G Orr; John R Cirrito; Nino Devidze; Kaitlyn Ho; Gui-Qiu Yu; Jorge J Palop; Lennart Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-06       Impact factor: 11.205

9.  Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase.

Authors:  Joanna L Jankowsky; Daniel J Fadale; Jeffrey Anderson; Guilian M Xu; Victoria Gonzales; Nancy A Jenkins; Neal G Copeland; Michael K Lee; Linda H Younkin; Steven L Wagner; Steven G Younkin; David R Borchelt
Journal:  Hum Mol Genet       Date:  2003-11-25       Impact factor: 6.150

10.  Association of epileptiform abnormalities and seizures in Alzheimer disease.

Authors:  Alice D Lam; Rani A Sarkis; Kyle R Pellerin; Jin Jing; Barbara A Dworetzky; Daniel B Hoch; Claire S Jacobs; Jong Woo Lee; Daniel S Weisholtz; Rodrigo Zepeda; M Brandon Westover; Andrew J Cole; Sydney S Cash
Journal:  Neurology       Date:  2020-08-06       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.